CALL FOR NOMINATIONS: NAS and NAM Initiative on Human Gene Editing
By Announcement,
Committee On Science, Technology, and Law
| 06. 24. 2015
Untitled Document
The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing. Human gene-editing technologies, such as CRISPR-Cas9, may lead to promising new treatments for disease. However, recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.
Our initiative will include an international summit in late 2015 to convene researchers and other experts to explore the scientific, ethical, legal, and policy issues associated with human gene-editing research. In addition, we will appoint a multidisciplinary, international committee to begin a comprehensive study of the scientific underpinnings and clinical, ethical, legal, and social implications of human gene editing. The committee will consider and recommend standards, guidelines, and practices governing the use of gene-editing technologies in biomedical research and medicine.
We are seeking nominations for both the planning committee for the international summit and the consensus study committee. We invite suggestions for scientists with expertise in molecular and developmental biology...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By John Donvan, WNYC and Open to Debate [with Marcy Darnovsky] | 04.23.2026
For complete introduction see Substack
Some call it eugenics, an unsettling step toward a world of “designer babies” reserved for the privileged. Others see something very different: a transformative scientific advance with the potential to prevent devastating genetic diseases before...